Related Experiment Videos
IBC's 5th Annual Conference on Blood Substitutes.
1Enzon, Inc., 40 Kingsbridge Road, Piscataway, NJ 08854, USA.
Expert Opinion on Investigational Drugs
|July 5, 2005
Summary
This conference summarized advancements in blood substitutes, including perfluorocarbons (PFCs) and hemoglobin-based oxygen carriers. Research focused on clinical trial progress, preclinical models, and novel oxygen delivery agents.
Area of Science:
- Biomedical Engineering
- Hematology
- Pharmacology
Background:
- The 5th Annual Conference on Blood Substitutes convened in 1997.
- Attended by 100+ researchers, scientists, and industry representatives.
- The field of blood substitutes has evolved significantly.
Purpose of the Study:
- To review progress in clinical trials for blood substitute compounds.
- To discuss preclinical models for predicting human efficacy.
- To explore novel oxygen delivery agents and approaches.
Main Methods:
- Presentations covered perfluorocarbons (PFCs) and hemoglobin-based oxygen carriers.
- Discussions included historical perspectives and future research directions.
- Summaries were divided into historical overview, company activities, and future study directions.
Main Results:
- Progress in human clinical trials was a key focus.
- Preclinical models were evaluated for predicting efficacy.
- Novel agents for oxygen delivery were presented.
Conclusions:
- The conference highlighted advancements in blood substitute technology.
- Future research will likely focus on laboratory and clinical investigations.
- The perceived need for blood substitutes has changed over time.